In 2023, Japan's market size for Paroxysmal Nocturnal Hemoglobinuria therapeutics was around USD 88.5 million, with expectations of growth throughout the forecast period (2024-2034). Projections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback